meglumine has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Borggrefe, M; Budjan, J; Doesch, C; Hohneck, A; Overhoff, D; Papavassiliu, T; Rudic, B; Sandberg, R; Szabo, K; Tueluemen, E | 1 |
| Aquaro, GD; Bracco, A; Carerj, S; Di Bella, G; Grigoratos, C; Habtemicael, YG; Martini, N; Proclemer, A; Sinagra, G; Todiere, G | 1 |
| Ariga, R; Chan, K; Daniels, MJ; Dass, S; Francis, J; Kramer, CM; Lewandowski, AJ; Mahmod, M; Neubauer, S; Ohuma, EO; Petersen, SE; Raman, B; Rodgers, C; Sivalokanathan, S; Smillie, R; Spartera, M; Watkins, H | 1 |
| Dixon, LJ; Hamilton, A; Horan, P; Johnston, N; Lyons, KS; McKeag, N; Noad, R | 1 |
| Prothmann, M; Rudolph, A; Schulz-Menger, J; Utz, W; von Knobelsdorff-Brenkenhoff, F; Wassmuth, R | 1 |
| Hänninen, H; Heliö, T; Hiippala, A; Holmström, M; Kaasalainen, T; Kivistö, S; Ojala, T; Ollila, L; Pöyhönen, P; Tallila, J; Vasilescu, C | 1 |
| Betancur, J; Carré, F; Donal, E; Garreau, M; Halbert, E; Hernández, A; Schnell, F; Simon, A; Tavard, F | 1 |
| Agudo-Quilez, P; Aguirre, N; Alfonso, F; Caballero, P; Jiménez-Borreguero, LJ; Olivera, MJ; Pozo, E; Viliani, D | 1 |
| Bakker, J; Brouwer, MA; Cramer, GE; Dieker, HJ; Fouraux, MA; Gommans, DF; Kofflard, MJ; Marcelis, CL; Michels, M; Timmermans, J; Verheugt, FW | 1 |
| Basha, T; Bellm, S; Jang, J; Kato, S; Manning, WJ; Maron, M; Nakamori, S; Nezafat, R | 1 |
| Da Pozzo, S; Faccioli, N; Foti, G; Guarise, A; Meneghetti, P; Morana, G | 1 |
| Ariti, C; Cook, C; Flett, AS; Hasleton, J; Hausenloy, D; Moon, JC; Muthurangu, V; Quarta, G | 1 |
1 trial(s) available for meglumine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
Topics: Adult; Cardiomyopathy, Hypertrophic; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardial Ischemia; Observer Variation; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Young Adult | 2014 |
11 other study(ies) available for meglumine and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Extent of Late Gadolinium Enhancement Predicts Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Contrast Media; Female; Fibrosis; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Thromboembolism; Time Factors | 2020 |
Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Contrast Media; Death, Sudden, Cardiac; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Time Factors | 2020 |
Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.
Topics: Cardiomyopathy, Hypertrophic; Contrast Media; Disease Progression; Female; Fibrosis; Gadolinium DTPA; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Prognosis; Retrospective Studies; Risk Factors | 2019 |
Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
Topics: Cardiomyopathy, Hypertrophic; Contrast Media; Death, Sudden, Cardiac; Delayed Diagnosis; Female; Follow-Up Studies; Gadolinium; Heart Septum; Humans; Incidence; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organometallic Compounds; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; United Kingdom | 2014 |
Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Topics: Adolescent; Adult; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Contrast Media; DNA Mutational Analysis; Electrocardiography; Female; Fibrosis; Genetic Predisposition to Disease; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Mutation; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2015 |
Registration of dynamic multiview 2D ultrasound and late gadolinium enhanced images of the heart: Application to hypertrophic cardiomyopathy characterization.
Topics: Algorithms; Cardiomyopathy, Hypertrophic; Contrast Media; Echocardiography; Elasticity Imaging Techniques; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Meglumine; Myocardium; Organometallic Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2016 |
Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage.
Topics: Aged; Cardiomyopathy, Hypertrophic; Contrast Media; Death, Sudden, Cardiac; Early Diagnosis; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prognosis; Risk Factors; Spain | 2016 |
High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Ambulatory Care; Biomarkers; Cardiomyopathy, Hypertrophic; Contrast Media; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Netherlands; Organometallic Compounds; Pilot Projects; Predictive Value of Tests; Prognosis; Troponin T; Up-Regulation; Ventricular Function, Left | 2017 |
Myocardial Native T1 Time in Patients With Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Case-Control Studies; Contrast Media; Female; Fibrosis; Heart; Heart Ventricles; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Organ Size; Organometallic Compounds | 2016 |
Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Contrast Media; Echocardiography; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies | 2011 |
Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Cicatrix; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; London; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardial Infarction; Myocardium; Observer Variation; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies | 2011 |